Page last updated: 2024-09-03

sr 46349b and Body Weight

sr 46349b has been researched along with Body Weight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaouloff, F; Kulikov, A; Mormède, P	1

Other Studies

1 other study(ies) available for sr 46349b and Body Weight

Article	Year
Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors. European journal of pharmacology, 1997, Sep-03, Volume: 334, Issue:1 Topics: Amphetamines; Animals; Anxiety; Behavior, Animal; Body Weight; Cerebral Cortex; Female; Fluorobenzenes; Ketanserin; Male; Maze Learning; Phenols; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists	1997

Article

Year

Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors.

European journal of pharmacology, 1997, Sep-03, Volume: 334, Issue:1

Topics: Amphetamines; Animals; Anxiety; Behavior, Animal; Body Weight; Cerebral Cortex; Female; Fluorobenzenes; Ketanserin; Male; Maze Learning; Phenols; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

1997